Discovery of novel HPPD inhibitors based on a combination strategy of pharmacophore, consensus docking and molecular dynamics

被引:7
|
作者
Wang, Jia-Yu [1 ]
Zhao, Li-Xia [1 ]
Shi, Juan [1 ]
Gao, Shuang [1 ]
Ye, Fei [1 ]
Fu, Ying [1 ]
机构
[1] Northeast Agr Univ, Coll Arts & Sci, Dept Chem, Harbin 150030, Peoples R China
关键词
HPPD inhibitor; Molecular dynamics; Consensus docking; Pharmacophore model; Enzyme activity; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITORS; HYDROXYPHENYLPYRUVATE DIOXYGENASE; IDENTIFICATION; DESIGN; DERIVATIVES; CHALLENGES; HERBICIDES;
D O I
10.1016/j.molliq.2022.119683
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
4-Hydroxyphenylpyruvate dioxygenase (HPPD), an Fe(II)/Co(II)-dependent non-heme oxygenase, is a vital enzyme in the tyrosine catabolic pathway and has been proved to be a very successful herbicides target with bleaching properties. In this process, pharmacophore modeling combined with consensus docking was used to discover new HPPD-inhibitors. A total of 322,686 compounds from Targetmol, Bailingwei, and ZINC were screened through a multilayered screening work. To avoid the defects existing in the single docking process, the consensus docking was employed to analyze the docking results. Five compounds with good performance were finally obtained, and all of them could produce stable coordination with cobalt ions and form good pi-pi interactions. Calculated binding free energy indicated that the van der Waals (vdW), lipophilic, and coulomb force interactions were the major components to the binding affinity. The enzyme activity confirmed that Flavokawain A and Silymarin displayed significant potency against AtHPPD in vitro. This work provides a worthful theoretical basis and an important lead skeleton for the reasonable devise of innovative HPPD herbicides. (c) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies
    Berishvili, Vladimir P.
    Kuimov, Alexander N.
    Voronkov, Andrew E.
    Radchenko, Eugene, V
    Kumar, Pradeep
    Choonara, Yahya E.
    Pillay, Viness
    Kamal, Ahmed
    Palyulin, Vladimir A.
    [J]. MOLECULES, 2020, 25 (14):
  • [42] Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
    Amaravadhi Harikishore
    Enlin Li
    Jia Jun Lee
    Nam-Joon Cho
    Ho Sup Yoon
    [J]. Molecular Diversity, 2015, 19 : 529 - 539
  • [43] Pharmacophore and molecular docking based identification of novel structurally diverse PDE-5 inhibitors
    Sarvesh Paliwal
    Anupama Mittal
    Mukta Sharma
    Anubhuti pandey
    Aarti Singh
    Shailendra Paliwal
    [J]. Medicinal Chemistry Research, 2015, 24 : 576 - 587
  • [44] Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation for identification of potential ERK inhibitors
    Tian, Yafeng
    Zhang, Mi
    Heng, Panpan
    Hou, Hua
    Wang, Baoshan
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (04): : 2153 - 2161
  • [45] Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors
    Garri Chilingaryan
    Narek Abelyan
    Arsen Sargsyan
    Karen Nazaryan
    Andre Serobian
    Hovakim Zakaryan
    [J]. Scientific Reports, 11
  • [46] Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT
    Matore, Balaji Wamanrao
    Roy, Partha Pratim
    Singh, Jagadish
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (22): : 13056 - 13077
  • [47] Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
    Harikishore, Amaravadhi
    Li, Enlin
    Lee, Jia Jun
    Cho, Nam-Joon
    Yoon, Ho Sup
    [J]. MOLECULAR DIVERSITY, 2015, 19 (03) : 529 - 539
  • [48] Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors
    Chilingaryan, Garri
    Abelyan, Narek
    Sargsyan, Arsen
    Nazaryan, Karen
    Serobian, Andre
    Zakaryan, Hovakim
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Pharmacophore and molecular docking based identification of novel structurally diverse PDE-5 inhibitors
    Paliwal, Sarvesh
    Mittal, Anupama
    Sharma, Mukta
    Pandey, Anubhuti
    Singh, Aarti
    Paliwal, Shailendra
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (02) : 576 - 587
  • [50] In silico approaches for the identification of novel ULK1 inhibitors: pharmacophore model, molecular docking and molecular dynamics simulations
    Yang, Yifan
    Ji, Cuicui
    Zhong, Qidi
    Yan, Hong
    Wang, Juan
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,